nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—hematologic cancer	0.186	0.706	CbGaD
Telmisartan—ABCB1—hematologic cancer	0.0776	0.294	CbGaD
Telmisartan—ABCG2—Clofarabine—hematologic cancer	0.0363	0.0805	CbGbCtD
Telmisartan—ABCC2—Daunorubicin—hematologic cancer	0.0236	0.0522	CbGbCtD
Telmisartan—ABCG2—Daunorubicin—hematologic cancer	0.0213	0.0472	CbGbCtD
Telmisartan—ABCG2—Teniposide—hematologic cancer	0.0185	0.041	CbGbCtD
Telmisartan—ABCG2—Cladribine—hematologic cancer	0.0177	0.0393	CbGbCtD
Telmisartan—ABCG2—Imatinib—hematologic cancer	0.0163	0.0362	CbGbCtD
Telmisartan—ABCG2—Nilotinib—hematologic cancer	0.0148	0.0329	CbGbCtD
Telmisartan—ABCG2—Dasatinib—hematologic cancer	0.0131	0.029	CbGbCtD
Telmisartan—ABCB1—Lenalidomide—hematologic cancer	0.0131	0.029	CbGbCtD
Telmisartan—ABCG2—Mitoxantrone—hematologic cancer	0.0129	0.0287	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—hematologic cancer	0.0117	0.0258	CbGbCtD
Telmisartan—ABCC2—Irinotecan—hematologic cancer	0.0113	0.025	CbGbCtD
Telmisartan—ABCG2—Irinotecan—hematologic cancer	0.0102	0.0226	CbGbCtD
Telmisartan—ABCC2—Vinblastine—hematologic cancer	0.01	0.0222	CbGbCtD
Telmisartan—CYP2C19—Bortezomib—hematologic cancer	0.00995	0.0221	CbGbCtD
Telmisartan—ABCC2—Vincristine—hematologic cancer	0.00985	0.0218	CbGbCtD
Telmisartan—ABCC2—Cisplatin—hematologic cancer	0.00919	0.0204	CbGbCtD
Telmisartan—ABCC2—Etoposide—hematologic cancer	0.00903	0.02	CbGbCtD
Telmisartan—ABCG2—Vincristine—hematologic cancer	0.00891	0.0197	CbGbCtD
Telmisartan—CYP2C19—Thalidomide—hematologic cancer	0.00867	0.0192	CbGbCtD
Telmisartan—ABCG2—Cisplatin—hematologic cancer	0.00831	0.0184	CbGbCtD
Telmisartan—CYP2C19—Teniposide—hematologic cancer	0.00827	0.0183	CbGbCtD
Telmisartan—ABCG2—Etoposide—hematologic cancer	0.00816	0.0181	CbGbCtD
Telmisartan—ABCB1—Daunorubicin—hematologic cancer	0.00768	0.017	CbGbCtD
Telmisartan—CYP2C19—Ifosfamide—hematologic cancer	0.00763	0.0169	CbGbCtD
Telmisartan—ABCB1—Alitretinoin—hematologic cancer	0.00752	0.0167	CbGbCtD
Telmisartan—ABCC2—Dexamethasone—hematologic cancer	0.00742	0.0165	CbGbCtD
Telmisartan—CYP2C19—Imatinib—hematologic cancer	0.00729	0.0162	CbGbCtD
Telmisartan—ABCG2—Dexamethasone—hematologic cancer	0.00671	0.0149	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—hematologic cancer	0.00616	0.0137	CbGbCtD
Telmisartan—ABCC2—Methotrexate—hematologic cancer	0.00596	0.0132	CbGbCtD
Telmisartan—ABCB1—Imatinib—hematologic cancer	0.00588	0.013	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—hematologic cancer	0.00557	0.0123	CbGbCtD
Telmisartan—ABCG2—Methotrexate—hematologic cancer	0.00539	0.012	CbGbCtD
Telmisartan—ABCB1—Nilotinib—hematologic cancer	0.00535	0.0119	CbGbCtD
Telmisartan—ABCB1—Vinorelbine—hematologic cancer	0.0053	0.0118	CbGbCtD
Telmisartan—CYP2C19—Prednisone—hematologic cancer	0.0048	0.0106	CbGbCtD
Telmisartan—ABCB1—Dasatinib—hematologic cancer	0.00472	0.0105	CbGbCtD
Telmisartan—ABCB1—Mitoxantrone—hematologic cancer	0.00467	0.0103	CbGbCtD
Telmisartan—ABCB1—Betamethasone—hematologic cancer	0.00416	0.00922	CbGbCtD
Telmisartan—ABCB1—Gemcitabine—hematologic cancer	0.00412	0.00914	CbGbCtD
Telmisartan—ABCB1—Prednisolone—hematologic cancer	0.0041	0.0091	CbGbCtD
Telmisartan—ABCB1—Prednisone—hematologic cancer	0.00388	0.00859	CbGbCtD
Telmisartan—ABCB1—Irinotecan—hematologic cancer	0.00367	0.00815	CbGbCtD
Telmisartan—ABCB1—Vinblastine—hematologic cancer	0.00327	0.00724	CbGbCtD
Telmisartan—ABCB1—Vincristine—hematologic cancer	0.00321	0.00712	CbGbCtD
Telmisartan—CYP2C19—Dexamethasone—hematologic cancer	0.003	0.00665	CbGbCtD
Telmisartan—ABCB1—Cisplatin—hematologic cancer	0.003	0.00664	CbGbCtD
Telmisartan—ABCB1—Etoposide—hematologic cancer	0.00294	0.00652	CbGbCtD
Telmisartan—ABCB1—Dexamethasone—hematologic cancer	0.00242	0.00536	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—hematologic cancer	0.00201	0.00445	CbGbCtD
Telmisartan—ABCB1—Methotrexate—hematologic cancer	0.00194	0.00431	CbGbCtD
Telmisartan—AGTR1—hematopoietic system—hematologic cancer	0.00102	0.0821	CbGeAlD
Telmisartan—SLCO1B3—lung—hematologic cancer	0.000973	0.0786	CbGeAlD
Telmisartan—PPARG—hematopoietic system—hematologic cancer	0.000836	0.0675	CbGeAlD
Telmisartan—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.000797	0.285	CbGdCrCtD
Telmisartan—AGTR1—blood—hematologic cancer	0.000673	0.0544	CbGeAlD
Telmisartan—CYP2C19—hematopoietic system—hematologic cancer	0.000631	0.051	CbGeAlD
Telmisartan—PPARG—Ponatinib—Imatinib—hematologic cancer	0.000604	0.216	CbGdCrCtD
Telmisartan—AGTR1—lung—hematologic cancer	0.00059	0.0477	CbGeAlD
Telmisartan—PPARG—Topotecan—Irinotecan—hematologic cancer	0.000572	0.204	CbGdCrCtD
Telmisartan—PPARG—Etoposide—Teniposide—hematologic cancer	0.000569	0.203	CbGdCrCtD
Telmisartan—AGTR1—testis—hematologic cancer	0.000557	0.045	CbGeAlD
Telmisartan—PPARG—blood—hematologic cancer	0.000554	0.0447	CbGeAlD
Telmisartan—PPARG—bone marrow—hematologic cancer	0.000536	0.0433	CbGeAlD
Telmisartan—ABCC2—blood—hematologic cancer	0.000487	0.0393	CbGeAlD
Telmisartan—PPARG—lung—hematologic cancer	0.000485	0.0392	CbGeAlD
Telmisartan—PPARG—testis—hematologic cancer	0.000458	0.037	CbGeAlD
Telmisartan—CYP2C19—blood—hematologic cancer	0.000418	0.0338	CbGeAlD
Telmisartan—AGTR1—lymph node—hematologic cancer	0.000404	0.0326	CbGeAlD
Telmisartan—ABCC2—testis—hematologic cancer	0.000403	0.0325	CbGeAlD
Telmisartan—ABCG2—blood—hematologic cancer	0.000355	0.0287	CbGeAlD
Telmisartan—ABCG2—bone marrow—hematologic cancer	0.000343	0.0278	CbGeAlD
Telmisartan—PPARG—lymph node—hematologic cancer	0.000332	0.0268	CbGeAlD
Telmisartan—Losartan—UGT1A1—hematologic cancer	0.000326	0.543	CrCbGaD
Telmisartan—ABCG2—lung—hematologic cancer	0.000311	0.0251	CbGeAlD
Telmisartan—ABCG2—testis—hematologic cancer	0.000294	0.0237	CbGeAlD
Telmisartan—ABCC2—lymph node—hematologic cancer	0.000292	0.0236	CbGeAlD
Telmisartan—ABCB1—hematopoietic system—hematologic cancer	0.000264	0.0213	CbGeAlD
Telmisartan—PPARG—Teniposide—Etoposide—hematologic cancer	0.000258	0.0921	CbGdCrCtD
Telmisartan—ABCG2—lymph node—hematologic cancer	0.000213	0.0172	CbGeAlD
Telmisartan—ABCB1—gonad—hematologic cancer	0.000201	0.0162	CbGeAlD
Telmisartan—ABCB1—blood—hematologic cancer	0.000175	0.0141	CbGeAlD
Telmisartan—ABCB1—bone marrow—hematologic cancer	0.000169	0.0137	CbGeAlD
Telmisartan—ABCB1—lung—hematologic cancer	0.000153	0.0124	CbGeAlD
Telmisartan—ABCB1—testis—hematologic cancer	0.000145	0.0117	CbGeAlD
Telmisartan—Candesartan—ABCB1—hematologic cancer	0.000118	0.197	CrCbGaD
Telmisartan—ABCB1—lymph node—hematologic cancer	0.000105	0.00848	CbGeAlD
Telmisartan—Losartan—ALB—hematologic cancer	7.99e-05	0.133	CrCbGaD
Telmisartan—Losartan—ABCB1—hematologic cancer	7.62e-05	0.127	CrCbGaD
Telmisartan—Rash—Cisplatin—hematologic cancer	1.58e-05	8.15e-05	CcSEcCtD
Telmisartan—Dermatitis—Cisplatin—hematologic cancer	1.58e-05	8.14e-05	CcSEcCtD
Telmisartan—Erythema—Epirubicin—hematologic cancer	1.58e-05	8.13e-05	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—hematologic cancer	1.58e-05	8.13e-05	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—hematologic cancer	1.57e-05	8.1e-05	CcSEcCtD
Telmisartan—Anorexia—Prednisone—hematologic cancer	1.57e-05	8.09e-05	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—hematologic cancer	1.56e-05	8.08e-05	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—hematologic cancer	1.56e-05	8.06e-05	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—hematologic cancer	1.56e-05	8.06e-05	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—hematologic cancer	1.56e-05	8.03e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Dexamethasone—hematologic cancer	1.56e-05	8.03e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Betamethasone—hematologic cancer	1.56e-05	8.03e-05	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—hematologic cancer	1.55e-05	8.02e-05	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—hematologic cancer	1.55e-05	8.02e-05	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—hematologic cancer	1.55e-05	8.02e-05	CcSEcCtD
Telmisartan—Tension—Epirubicin—hematologic cancer	1.55e-05	7.98e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.54e-05	7.97e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Betamethasone—hematologic cancer	1.54e-05	7.97e-05	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—hematologic cancer	1.54e-05	7.97e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Triamcinolone—hematologic cancer	1.53e-05	7.91e-05	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—hematologic cancer	1.53e-05	7.9e-05	CcSEcCtD
Telmisartan—Back pain—Epirubicin—hematologic cancer	1.52e-05	7.87e-05	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—hematologic cancer	1.52e-05	7.84e-05	CcSEcCtD
Telmisartan—Malaise—Methotrexate—hematologic cancer	1.52e-05	7.84e-05	CcSEcCtD
Telmisartan—Dizziness—Etoposide—hematologic cancer	1.52e-05	7.83e-05	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—hematologic cancer	1.51e-05	7.82e-05	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—hematologic cancer	1.51e-05	7.81e-05	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—hematologic cancer	1.51e-05	7.81e-05	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—hematologic cancer	1.51e-05	7.79e-05	CcSEcCtD
Telmisartan—Chills—Doxorubicin—hematologic cancer	1.5e-05	7.76e-05	CcSEcCtD
Telmisartan—Urticaria—Betamethasone—hematologic cancer	1.5e-05	7.74e-05	CcSEcCtD
Telmisartan—Urticaria—Dexamethasone—hematologic cancer	1.5e-05	7.74e-05	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.5e-05	7.73e-05	CcSEcCtD
Telmisartan—Dizziness—Prednisolone—hematologic cancer	1.5e-05	7.72e-05	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—hematologic cancer	1.5e-05	7.72e-05	CcSEcCtD
Telmisartan—Asthenia—Triamcinolone—hematologic cancer	1.49e-05	7.71e-05	CcSEcCtD
Telmisartan—Abdominal pain—Betamethasone—hematologic cancer	1.49e-05	7.71e-05	CcSEcCtD
Telmisartan—Abdominal pain—Dexamethasone—hematologic cancer	1.49e-05	7.71e-05	CcSEcCtD
Telmisartan—Body temperature increased—Betamethasone—hematologic cancer	1.49e-05	7.71e-05	CcSEcCtD
Telmisartan—Body temperature increased—Dexamethasone—hematologic cancer	1.49e-05	7.71e-05	CcSEcCtD
Telmisartan—Nausea—Cisplatin—hematologic cancer	1.49e-05	7.68e-05	CcSEcCtD
Telmisartan—Insomnia—Prednisone—hematologic cancer	1.49e-05	7.68e-05	CcSEcCtD
Telmisartan—Paraesthesia—Prednisone—hematologic cancer	1.48e-05	7.62e-05	CcSEcCtD
Telmisartan—Pruritus—Triamcinolone—hematologic cancer	1.47e-05	7.6e-05	CcSEcCtD
Telmisartan—Cough—Methotrexate—hematologic cancer	1.47e-05	7.58e-05	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—hematologic cancer	1.47e-05	7.57e-05	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—hematologic cancer	1.46e-05	7.55e-05	CcSEcCtD
Telmisartan—Vomiting—Etoposide—hematologic cancer	1.46e-05	7.53e-05	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—hematologic cancer	1.46e-05	7.53e-05	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—hematologic cancer	1.46e-05	7.53e-05	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—hematologic cancer	1.46e-05	7.52e-05	CcSEcCtD
Telmisartan—Dyspepsia—Prednisone—hematologic cancer	1.45e-05	7.47e-05	CcSEcCtD
Telmisartan—Rash—Etoposide—hematologic cancer	1.45e-05	7.47e-05	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—hematologic cancer	1.44e-05	7.46e-05	CcSEcCtD
Telmisartan—Headache—Etoposide—hematologic cancer	1.44e-05	7.42e-05	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—hematologic cancer	1.44e-05	7.42e-05	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—hematologic cancer	1.43e-05	7.4e-05	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—hematologic cancer	1.43e-05	7.4e-05	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—hematologic cancer	1.43e-05	7.4e-05	CcSEcCtD
Telmisartan—Tension—Doxorubicin—hematologic cancer	1.43e-05	7.39e-05	CcSEcCtD
Telmisartan—Decreased appetite—Prednisone—hematologic cancer	1.43e-05	7.38e-05	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—hematologic cancer	1.43e-05	7.37e-05	CcSEcCtD
Telmisartan—Rash—Prednisolone—hematologic cancer	1.43e-05	7.37e-05	CcSEcCtD
Telmisartan—Dermatitis—Prednisolone—hematologic cancer	1.42e-05	7.36e-05	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.42e-05	7.35e-05	CcSEcCtD
Telmisartan—Malaise—Epirubicin—hematologic cancer	1.42e-05	7.34e-05	CcSEcCtD
Telmisartan—Fatigue—Prednisone—hematologic cancer	1.42e-05	7.32e-05	CcSEcCtD
Telmisartan—Headache—Prednisolone—hematologic cancer	1.42e-05	7.32e-05	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—hematologic cancer	1.42e-05	7.31e-05	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—hematologic cancer	1.42e-05	7.31e-05	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—hematologic cancer	1.42e-05	7.31e-05	CcSEcCtD
Telmisartan—Syncope—Epirubicin—hematologic cancer	1.41e-05	7.29e-05	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—hematologic cancer	1.41e-05	7.28e-05	CcSEcCtD
Telmisartan—Constipation—Prednisone—hematologic cancer	1.41e-05	7.26e-05	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—hematologic cancer	1.4e-05	7.24e-05	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—hematologic cancer	1.39e-05	7.19e-05	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—hematologic cancer	1.38e-05	7.15e-05	CcSEcCtD
Telmisartan—Dizziness—Triamcinolone—hematologic cancer	1.38e-05	7.1e-05	CcSEcCtD
Telmisartan—Cough—Epirubicin—hematologic cancer	1.37e-05	7.1e-05	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—hematologic cancer	1.37e-05	7.09e-05	CcSEcCtD
Telmisartan—Infection—Methotrexate—hematologic cancer	1.36e-05	7.05e-05	CcSEcCtD
Telmisartan—Nausea—Etoposide—hematologic cancer	1.36e-05	7.03e-05	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—hematologic cancer	1.36e-05	7.02e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisone—hematologic cancer	1.35e-05	6.99e-05	CcSEcCtD
Telmisartan—Asthenia—Betamethasone—hematologic cancer	1.35e-05	6.99e-05	CcSEcCtD
Telmisartan—Asthenia—Dexamethasone—hematologic cancer	1.35e-05	6.99e-05	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—hematologic cancer	1.35e-05	6.98e-05	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—hematologic cancer	1.35e-05	6.96e-05	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—hematologic cancer	1.35e-05	6.96e-05	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—hematologic cancer	1.34e-05	6.95e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Prednisone—hematologic cancer	1.34e-05	6.94e-05	CcSEcCtD
Telmisartan—Nausea—Prednisolone—hematologic cancer	1.34e-05	6.94e-05	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—hematologic cancer	1.34e-05	6.93e-05	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—hematologic cancer	1.34e-05	6.93e-05	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—hematologic cancer	1.34e-05	6.93e-05	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—hematologic cancer	1.34e-05	6.9e-05	CcSEcCtD
Telmisartan—Pruritus—Betamethasone—hematologic cancer	1.34e-05	6.9e-05	CcSEcCtD
Telmisartan—Pruritus—Dexamethasone—hematologic cancer	1.34e-05	6.9e-05	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—hematologic cancer	1.33e-05	6.89e-05	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.33e-05	6.88e-05	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—hematologic cancer	1.33e-05	6.86e-05	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—hematologic cancer	1.32e-05	6.84e-05	CcSEcCtD
Telmisartan—Vomiting—Triamcinolone—hematologic cancer	1.32e-05	6.83e-05	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—hematologic cancer	1.31e-05	6.79e-05	CcSEcCtD
Telmisartan—Rash—Triamcinolone—hematologic cancer	1.31e-05	6.77e-05	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—hematologic cancer	1.31e-05	6.77e-05	CcSEcCtD
Telmisartan—Dermatitis—Triamcinolone—hematologic cancer	1.31e-05	6.77e-05	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—hematologic cancer	1.31e-05	6.76e-05	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—hematologic cancer	1.31e-05	6.76e-05	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—hematologic cancer	1.31e-05	6.75e-05	CcSEcCtD
Telmisartan—Urticaria—Prednisone—hematologic cancer	1.31e-05	6.74e-05	CcSEcCtD
Telmisartan—Headache—Triamcinolone—hematologic cancer	1.3e-05	6.73e-05	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—hematologic cancer	1.3e-05	6.71e-05	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—hematologic cancer	1.3e-05	6.71e-05	CcSEcCtD
Telmisartan—Diarrhoea—Dexamethasone—hematologic cancer	1.29e-05	6.67e-05	CcSEcCtD
Telmisartan—Diarrhoea—Betamethasone—hematologic cancer	1.29e-05	6.67e-05	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—hematologic cancer	1.29e-05	6.65e-05	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—hematologic cancer	1.29e-05	6.64e-05	CcSEcCtD
Telmisartan—Oedema—Epirubicin—hematologic cancer	1.29e-05	6.64e-05	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—hematologic cancer	1.28e-05	6.63e-05	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—hematologic cancer	1.28e-05	6.62e-05	CcSEcCtD
Telmisartan—Infection—Epirubicin—hematologic cancer	1.28e-05	6.6e-05	CcSEcCtD
Telmisartan—Cough—Doxorubicin—hematologic cancer	1.27e-05	6.57e-05	CcSEcCtD
Telmisartan—Shock—Epirubicin—hematologic cancer	1.26e-05	6.53e-05	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—hematologic cancer	1.26e-05	6.51e-05	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—hematologic cancer	1.26e-05	6.5e-05	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—hematologic cancer	1.26e-05	6.5e-05	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—hematologic cancer	1.25e-05	6.48e-05	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.25e-05	6.46e-05	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—hematologic cancer	1.25e-05	6.45e-05	CcSEcCtD
Telmisartan—Dizziness—Dexamethasone—hematologic cancer	1.25e-05	6.45e-05	CcSEcCtD
Telmisartan—Dizziness—Betamethasone—hematologic cancer	1.25e-05	6.45e-05	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—hematologic cancer	1.24e-05	6.42e-05	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—hematologic cancer	1.24e-05	6.42e-05	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—hematologic cancer	1.24e-05	6.41e-05	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—hematologic cancer	1.24e-05	6.41e-05	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—hematologic cancer	1.24e-05	6.41e-05	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—hematologic cancer	1.24e-05	6.39e-05	CcSEcCtD
Telmisartan—Nausea—Triamcinolone—hematologic cancer	1.24e-05	6.38e-05	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—hematologic cancer	1.23e-05	6.37e-05	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.23e-05	6.36e-05	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—hematologic cancer	1.23e-05	6.33e-05	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—hematologic cancer	1.23e-05	6.33e-05	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—hematologic cancer	1.22e-05	6.32e-05	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—hematologic cancer	1.22e-05	6.31e-05	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—hematologic cancer	1.21e-05	6.27e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Prednisone—hematologic cancer	1.21e-05	6.25e-05	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—hematologic cancer	1.21e-05	6.24e-05	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—hematologic cancer	1.2e-05	6.2e-05	CcSEcCtD
Telmisartan—Vomiting—Dexamethasone—hematologic cancer	1.2e-05	6.2e-05	CcSEcCtD
Telmisartan—Vomiting—Betamethasone—hematologic cancer	1.2e-05	6.2e-05	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—hematologic cancer	1.19e-05	6.17e-05	CcSEcCtD
Telmisartan—Rash—Dexamethasone—hematologic cancer	1.19e-05	6.15e-05	CcSEcCtD
Telmisartan—Rash—Betamethasone—hematologic cancer	1.19e-05	6.15e-05	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—hematologic cancer	1.19e-05	6.14e-05	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—hematologic cancer	1.19e-05	6.14e-05	CcSEcCtD
Telmisartan—Dermatitis—Dexamethasone—hematologic cancer	1.19e-05	6.14e-05	CcSEcCtD
Telmisartan—Dermatitis—Betamethasone—hematologic cancer	1.19e-05	6.14e-05	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.19e-05	6.12e-05	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—hematologic cancer	1.18e-05	6.12e-05	CcSEcCtD
Telmisartan—Headache—Betamethasone—hematologic cancer	1.18e-05	6.11e-05	CcSEcCtD
Telmisartan—Headache—Dexamethasone—hematologic cancer	1.18e-05	6.11e-05	CcSEcCtD
Telmisartan—Infection—Doxorubicin—hematologic cancer	1.18e-05	6.1e-05	CcSEcCtD
Telmisartan—Asthenia—Prednisone—hematologic cancer	1.18e-05	6.09e-05	CcSEcCtD
Telmisartan—Pain—Methotrexate—hematologic cancer	1.17e-05	6.07e-05	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.17e-05	6.05e-05	CcSEcCtD
Telmisartan—Shock—Doxorubicin—hematologic cancer	1.17e-05	6.04e-05	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—hematologic cancer	1.17e-05	6.02e-05	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—hematologic cancer	1.16e-05	6.01e-05	CcSEcCtD
Telmisartan—Pruritus—Prednisone—hematologic cancer	1.16e-05	6.01e-05	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—hematologic cancer	1.16e-05	6e-05	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—hematologic cancer	1.16e-05	6e-05	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—hematologic cancer	1.16e-05	5.97e-05	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—hematologic cancer	1.15e-05	5.96e-05	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—hematologic cancer	1.15e-05	5.94e-05	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—hematologic cancer	1.15e-05	5.92e-05	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—hematologic cancer	1.14e-05	5.9e-05	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—hematologic cancer	1.13e-05	5.86e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—hematologic cancer	1.13e-05	5.85e-05	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—hematologic cancer	1.13e-05	5.84e-05	CcSEcCtD
Telmisartan—Diarrhoea—Prednisone—hematologic cancer	1.12e-05	5.81e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—hematologic cancer	1.12e-05	5.8e-05	CcSEcCtD
Telmisartan—Nausea—Betamethasone—hematologic cancer	1.12e-05	5.79e-05	CcSEcCtD
Telmisartan—Nausea—Dexamethasone—hematologic cancer	1.12e-05	5.79e-05	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—hematologic cancer	1.12e-05	5.77e-05	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—hematologic cancer	1.11e-05	5.74e-05	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.11e-05	5.73e-05	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—hematologic cancer	1.11e-05	5.72e-05	CcSEcCtD
Telmisartan—Constipation—Epirubicin—hematologic cancer	1.1e-05	5.68e-05	CcSEcCtD
Telmisartan—Pain—Epirubicin—hematologic cancer	1.1e-05	5.68e-05	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—hematologic cancer	1.09e-05	5.64e-05	CcSEcCtD
Telmisartan—Dizziness—Prednisone—hematologic cancer	1.09e-05	5.61e-05	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—hematologic cancer	1.09e-05	5.61e-05	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—hematologic cancer	1.09e-05	5.61e-05	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.08e-05	5.6e-05	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—hematologic cancer	1.08e-05	5.56e-05	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—hematologic cancer	1.07e-05	5.52e-05	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—hematologic cancer	1.06e-05	5.48e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—hematologic cancer	1.06e-05	5.47e-05	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—hematologic cancer	1.06e-05	5.46e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—hematologic cancer	1.05e-05	5.43e-05	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—hematologic cancer	1.05e-05	5.41e-05	CcSEcCtD
Telmisartan—Vomiting—Prednisone—hematologic cancer	1.04e-05	5.4e-05	CcSEcCtD
Telmisartan—Rash—Prednisone—hematologic cancer	1.04e-05	5.35e-05	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—hematologic cancer	1.04e-05	5.35e-05	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—hematologic cancer	1.03e-05	5.34e-05	CcSEcCtD
Telmisartan—Headache—Prednisone—hematologic cancer	1.03e-05	5.32e-05	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.03e-05	5.3e-05	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—hematologic cancer	1.03e-05	5.3e-05	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—hematologic cancer	1.02e-05	5.27e-05	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—hematologic cancer	1.02e-05	5.25e-05	CcSEcCtD
Telmisartan—Pain—Doxorubicin—hematologic cancer	1.02e-05	5.25e-05	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—hematologic cancer	1.02e-05	5.25e-05	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—hematologic cancer	1.02e-05	5.25e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—hematologic cancer	1.01e-05	5.23e-05	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—hematologic cancer	9.86e-06	5.09e-05	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—hematologic cancer	9.8e-06	5.06e-05	CcSEcCtD
Telmisartan—Nausea—Prednisone—hematologic cancer	9.76e-06	5.04e-05	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.73e-06	5.02e-05	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—hematologic cancer	9.72e-06	5.02e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—hematologic cancer	9.47e-06	4.89e-05	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—hematologic cancer	9.45e-06	4.88e-05	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—hematologic cancer	9.4e-06	4.86e-05	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—hematologic cancer	9.4e-06	4.86e-05	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—hematologic cancer	9.4e-06	4.85e-05	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—hematologic cancer	9.22e-06	4.76e-05	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—hematologic cancer	9.09e-06	4.7e-05	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—hematologic cancer	9.08e-06	4.69e-05	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—hematologic cancer	8.8e-06	4.54e-05	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—hematologic cancer	8.76e-06	4.53e-05	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—hematologic cancer	8.73e-06	4.51e-05	CcSEcCtD
Telmisartan—Rash—Methotrexate—hematologic cancer	8.66e-06	4.47e-05	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—hematologic cancer	8.65e-06	4.47e-05	CcSEcCtD
Telmisartan—Headache—Methotrexate—hematologic cancer	8.6e-06	4.44e-05	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—hematologic cancer	8.53e-06	4.41e-05	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—hematologic cancer	8.5e-06	4.39e-05	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—hematologic cancer	8.41e-06	4.35e-05	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—hematologic cancer	8.17e-06	4.22e-05	CcSEcCtD
Telmisartan—Nausea—Methotrexate—hematologic cancer	8.16e-06	4.21e-05	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—hematologic cancer	8.14e-06	4.2e-05	CcSEcCtD
Telmisartan—Rash—Epirubicin—hematologic cancer	8.1e-06	4.19e-05	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—hematologic cancer	8.1e-06	4.18e-05	CcSEcCtD
Telmisartan—Headache—Epirubicin—hematologic cancer	8.05e-06	4.16e-05	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—hematologic cancer	7.87e-06	4.06e-05	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—FOXO1—hematologic cancer	7.84e-06	0.000104	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—hematologic cancer	7.84e-06	0.000104	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFRB—hematologic cancer	7.83e-06	0.000104	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—hematologic cancer	7.82e-06	0.000104	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—hematologic cancer	7.8e-06	0.000103	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—hematologic cancer	7.75e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	7.74e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	7.72e-06	0.000102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFRA—hematologic cancer	7.71e-06	0.000102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAK1—hematologic cancer	7.68e-06	0.000102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRKCG—hematologic cancer	7.68e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.68e-06	0.000102	CbGpPWpGaD
Telmisartan—Nausea—Epirubicin—hematologic cancer	7.64e-06	3.94e-05	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—MAPK3—hematologic cancer	7.57e-06	0.0001	CbGpPWpGaD
Telmisartan—Vomiting—Doxorubicin—hematologic cancer	7.56e-06	3.91e-05	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.54e-06	9.99e-05	CbGpPWpGaD
Telmisartan—Rash—Doxorubicin—hematologic cancer	7.5e-06	3.87e-05	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—hematologic cancer	7.49e-06	3.87e-05	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	7.48e-06	9.91e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	7.47e-06	9.89e-05	CbGpPWpGaD
Telmisartan—Headache—Doxorubicin—hematologic cancer	7.45e-06	3.85e-05	CcSEcCtD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.44e-06	9.86e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTHFR—hematologic cancer	7.42e-06	9.83e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FHL2—hematologic cancer	7.41e-06	9.82e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—hematologic cancer	7.38e-06	9.77e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK14—hematologic cancer	7.38e-06	9.77e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—hematologic cancer	7.34e-06	9.72e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	7.3e-06	9.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGRN—hematologic cancer	7.27e-06	9.63e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR1—hematologic cancer	7.24e-06	9.59e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FHL2—hematologic cancer	7.23e-06	9.58e-05	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	7.19e-06	9.52e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2RA—hematologic cancer	7.17e-06	9.5e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—hematologic cancer	7.16e-06	9.49e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NCOR1—hematologic cancer	7.16e-06	9.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	7.12e-06	9.43e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—hematologic cancer	7.12e-06	9.43e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGRN—hematologic cancer	7.09e-06	9.4e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—hematologic cancer	7.09e-06	9.39e-05	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—hematologic cancer	7.06e-06	3.65e-05	CcSEcCtD
Telmisartan—PPARG—Gene Expression—NOTCH1—hematologic cancer	7e-06	9.27e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	6.92e-06	9.17e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDGFB—hematologic cancer	6.92e-06	9.17e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—IDH2—hematologic cancer	6.89e-06	9.13e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMMR—hematologic cancer	6.89e-06	9.13e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—hematologic cancer	6.86e-06	9.08e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CD44—hematologic cancer	6.81e-06	9.03e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NQO1—hematologic cancer	6.81e-06	9.03e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—hematologic cancer	6.8e-06	9.01e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSC2—hematologic cancer	6.76e-06	8.96e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	6.74e-06	8.93e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—IDH2—hematologic cancer	6.72e-06	8.91e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMMR—hematologic cancer	6.72e-06	8.91e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.54e-06	8.66e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGFR3—hematologic cancer	6.51e-06	8.62e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.5e-06	8.61e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ARNTL—hematologic cancer	6.48e-06	8.58e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYCS—hematologic cancer	6.45e-06	8.54e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK14—hematologic cancer	6.44e-06	8.53e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HSP90AA1—hematologic cancer	6.41e-06	8.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	6.38e-06	8.45e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CREBBP—hematologic cancer	6.34e-06	8.4e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—hematologic cancer	6.33e-06	8.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ARNTL—hematologic cancer	6.32e-06	8.37e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—hematologic cancer	6.32e-06	8.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ACP5—hematologic cancer	6.3e-06	8.35e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA9—hematologic cancer	6.3e-06	8.35e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FN1—hematologic cancer	6.24e-06	8.27e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	6.23e-06	8.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOR2—hematologic cancer	6.22e-06	8.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	6.2e-06	8.22e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	6.19e-06	8.2e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BAD—hematologic cancer	6.17e-06	8.17e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKBIA—hematologic cancer	6.17e-06	8.17e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ACP5—hematologic cancer	6.15e-06	8.15e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA9—hematologic cancer	6.15e-06	8.15e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—hematologic cancer	6.11e-06	8.09e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOR2—hematologic cancer	6.07e-06	8.04e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD80—hematologic cancer	5.99e-06	7.93e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—hematologic cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—hematologic cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—hematologic cancer	5.97e-06	7.91e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—IDH1—hematologic cancer	5.92e-06	7.85e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTPN11—hematologic cancer	5.87e-06	7.77e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCC3—hematologic cancer	5.86e-06	7.76e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TXN—hematologic cancer	5.86e-06	7.76e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTO1—hematologic cancer	5.86e-06	7.76e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—IDH1—hematologic cancer	5.78e-06	7.66e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CREBBP—hematologic cancer	5.78e-06	7.66e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—hematologic cancer	5.78e-06	7.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	5.78e-06	7.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	5.73e-06	7.59e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SPHK1—hematologic cancer	5.73e-06	7.59e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—hematologic cancer	5.72e-06	7.58e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TXN—hematologic cancer	5.72e-06	7.57e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTO1—hematologic cancer	5.72e-06	7.57e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCC3—hematologic cancer	5.72e-06	7.57e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CREB1—hematologic cancer	5.69e-06	7.53e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—hematologic cancer	5.68e-06	7.53e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—hematologic cancer	5.62e-06	7.44e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SPHK1—hematologic cancer	5.6e-06	7.41e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.58e-06	7.39e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL2—hematologic cancer	5.56e-06	7.37e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6R—hematologic cancer	5.55e-06	7.35e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CREBBP—hematologic cancer	5.54e-06	7.34e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—hematologic cancer	5.53e-06	7.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.51e-06	7.3e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	5.48e-06	7.26e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—hematologic cancer	5.41e-06	7.17e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—hematologic cancer	5.38e-06	7.13e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—UGT1A1—hematologic cancer	5.38e-06	7.12e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.36e-06	7.1e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.36e-06	7.1e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—hematologic cancer	5.32e-06	7.05e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAP2K1—hematologic cancer	5.29e-06	7e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.27e-06	6.98e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—hematologic cancer	5.25e-06	6.96e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CRABP1—hematologic cancer	5.23e-06	6.93e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC22A1—hematologic cancer	5.23e-06	6.93e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—hematologic cancer	5.22e-06	6.92e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NCOR1—hematologic cancer	5.22e-06	6.92e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.22e-06	6.92e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.2e-06	6.89e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	5.18e-06	6.85e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—hematologic cancer	5.14e-06	6.81e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—hematologic cancer	5.1e-06	6.76e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALOX5—hematologic cancer	5.1e-06	6.75e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.1e-06	6.75e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NUP98—hematologic cancer	5.06e-06	6.7e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF2—hematologic cancer	5.03e-06	6.66e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3R1—hematologic cancer	4.96e-06	6.57e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NUP98—hematologic cancer	4.94e-06	6.54e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CREBBP—hematologic cancer	4.93e-06	6.53e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADCY7—hematologic cancer	4.91e-06	6.5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOA3—hematologic cancer	4.91e-06	6.5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NUP214—hematologic cancer	4.87e-06	6.46e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.82e-06	6.39e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAK2—hematologic cancer	4.82e-06	6.38e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOA3—hematologic cancer	4.79e-06	6.35e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADCY7—hematologic cancer	4.79e-06	6.35e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	4.78e-06	6.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.78e-06	6.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTR—hematologic cancer	4.78e-06	6.33e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NUP214—hematologic cancer	4.76e-06	6.3e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—hematologic cancer	4.72e-06	6.26e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—hematologic cancer	4.71e-06	6.23e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO2—hematologic cancer	4.68e-06	6.2e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—hematologic cancer	4.68e-06	6.19e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTR—hematologic cancer	4.66e-06	6.17e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCG2—hematologic cancer	4.66e-06	6.17e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—hematologic cancer	4.62e-06	6.11e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—hematologic cancer	4.62e-06	6.11e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—hematologic cancer	4.58e-06	6.06e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—hematologic cancer	4.58e-06	6.06e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO2—hematologic cancer	4.57e-06	6.05e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.54e-06	6.02e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.47e-06	5.92e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SDC1—hematologic cancer	4.44e-06	5.88e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—hematologic cancer	4.43e-06	5.87e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3R1—hematologic cancer	4.42e-06	5.85e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—hematologic cancer	4.37e-06	5.79e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SDC1—hematologic cancer	4.33e-06	5.74e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.3e-06	5.7e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—hematologic cancer	4.3e-06	5.69e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—hematologic cancer	4.25e-06	5.63e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.24e-06	5.62e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—hematologic cancer	4.21e-06	5.58e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—hematologic cancer	4.2e-06	5.57e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.19e-06	5.55e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—hematologic cancer	4.18e-06	5.54e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.15e-06	5.5e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—hematologic cancer	4.13e-06	5.47e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—hematologic cancer	4.1e-06	5.43e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—hematologic cancer	4.09e-06	5.42e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—hematologic cancer	4.08e-06	5.4e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4e-06	5.3e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—hematologic cancer	3.96e-06	5.25e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—hematologic cancer	3.96e-06	5.24e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—hematologic cancer	3.94e-06	5.21e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.89e-06	5.15e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.88e-06	5.14e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—hematologic cancer	3.87e-06	5.13e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK8—hematologic cancer	3.87e-06	5.13e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—hematologic cancer	3.86e-06	5.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CD44—hematologic cancer	3.77e-06	5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NQO1—hematologic cancer	3.77e-06	5e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—hematologic cancer	3.77e-06	5e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—hematologic cancer	3.76e-06	4.99e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.7e-06	4.9e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CD44—hematologic cancer	3.68e-06	4.88e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NQO1—hematologic cancer	3.68e-06	4.88e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—hematologic cancer	3.67e-06	4.86e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CREBBP—hematologic cancer	3.6e-06	4.76e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—hematologic cancer	3.57e-06	4.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYCS—hematologic cancer	3.57e-06	4.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.55e-06	4.7e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—hematologic cancer	3.54e-06	4.69e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—hematologic cancer	3.53e-06	4.67e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—hematologic cancer	3.52e-06	4.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYCS—hematologic cancer	3.49e-06	4.62e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.46e-06	4.59e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—hematologic cancer	3.41e-06	4.52e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—hematologic cancer	3.38e-06	4.48e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—hematologic cancer	3.37e-06	4.46e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—hematologic cancer	3.36e-06	4.45e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—hematologic cancer	3.29e-06	4.35e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—hematologic cancer	3.28e-06	4.34e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3R1—hematologic cancer	3.22e-06	4.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.19e-06	4.23e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.15e-06	4.17e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—hematologic cancer	3.07e-06	4.07e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.05e-06	4.03e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—hematologic cancer	3.04e-06	4.02e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.98e-06	3.95e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.97e-06	3.94e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.91e-06	3.86e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.89e-06	3.83e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.89e-06	3.83e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NCOR1—hematologic cancer	2.82e-06	3.74e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—hematologic cancer	2.82e-06	3.74e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—hematologic cancer	2.79e-06	3.7e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—hematologic cancer	2.7e-06	3.58e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—hematologic cancer	2.61e-06	3.46e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—hematologic cancer	2.58e-06	3.42e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—hematologic cancer	2.57e-06	3.4e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.56e-06	3.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—hematologic cancer	2.5e-06	3.31e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—hematologic cancer	2.48e-06	3.29e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—hematologic cancer	2.47e-06	3.27e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—hematologic cancer	2.45e-06	3.24e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—hematologic cancer	2.38e-06	3.15e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—hematologic cancer	2.28e-06	3.02e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.15e-06	2.85e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.1e-06	2.78e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—hematologic cancer	2.03e-06	2.69e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.99e-06	2.64e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CREBBP—hematologic cancer	1.94e-06	2.58e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.89e-06	2.5e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—hematologic cancer	1.86e-06	2.47e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.84e-06	2.44e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—hematologic cancer	1.82e-06	2.41e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.81e-06	2.4e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.78e-06	2.36e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.74e-06	2.31e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.65e-06	2.18e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.61e-06	2.13e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—hematologic cancer	1.48e-06	1.96e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—hematologic cancer	1.42e-06	1.88e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—hematologic cancer	1.39e-06	1.84e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—hematologic cancer	1.36e-06	1.8e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—hematologic cancer	1.32e-06	1.75e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1e-06	1.33e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.79e-07	1.3e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—hematologic cancer	8.2e-07	1.09e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—hematologic cancer	8e-07	1.06e-05	CbGpPWpGaD
